Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Intern Med. 2014 Mar;275(3):251–283. doi: 10.1111/joim.12191

Table 5.

Outcomes used in clinical trials for Alzheimer’s disease and mild cognitive impairment

Staging Cognition ADLs Global
Mini-Mental State Examination (MMSE) Alzheimer’s Disease Assessment Scale- cognitive subscale (ADAS-cog) Alzheimer’s Disease Cooperative Study- Activities of Daily Living (ADCS-ADL) Alzheimer’s Disease Cooperative Study- Clinical Global Impression of Change (ADCS-CGIC)
Clinical Dementia Rating Scale (CDR) Neuropsychological Test Battery (NTB) Disability in Alzheimer’s Disease (DAD) Clinical Dementia Rating Scale-sum of boxes (CDR-SB)
Global Deterioration Scale (GDS) Mini-Mental State Examination (MMSE) Progressive Deterioration Scale (PDS) Gottfries-Brane-Steen (GBS)
Gottfries-Brane-Steen (GBS) Severe Impairment Battery (SIB) Bristol activities of daily living (ADL)